Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Ringelstein

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|June 10, 2021
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive PatientsIlya Ayzenberg, Daniel Richter, Eugenia Henke, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Annals of Neurology|March 25, 2018
Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitisStefanie H Mueller, Anna Färber, Harald Prüss, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and originSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.
BMJ Neurology Open|October 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)Anna Walz, Daria Tkachenko, Martin W Hümmert, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcomeSven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Neurology and Therapy|July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysisMahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Neurology(R) Neuroimmunology & Neuroinflammation|June 10, 2021
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive PatientsIlya Ayzenberg, Daniel Richter, Eugenia Henke, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Annals of Neurology|March 25, 2018
Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitisStefanie H Mueller, Anna Färber, Harald Prüss, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and originSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.
BMJ Neurology Open|October 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)Anna Walz, Daria Tkachenko, Martin W Hümmert, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcomeSven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Neurology and Therapy|July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysisMahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.
Pageof 12